Pharmaceuticals, Biotechnology and Life Sciences
BEDFORD, Mass.–(BUSINESS WIRE)–$OCUL #OCUTX–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative…
– Friedreich’s ataxia chosen as first neurological indication – Reported Phase 1b data for lead immuno-oncology candidate in solid tumors…
– Friedreich’s ataxia chosen as first neurological indication – Reported Phase 1b data for lead immuno-oncology candidate in solid tumors…
Novel Mechanism of Action Inhibits Pathological Activation of Microglial Cells and Prevents Neuronal Cell Death GERMANTOWN, Md.–(BUSINESS WIRE)–Neuraly, a clinical…
Novel Mechanism of Action Inhibits Pathological Activation of Microglial Cells and Prevents Neuronal Cell Death GERMANTOWN, Md.–(BUSINESS WIRE)–Neuraly, a clinical…
− GIVLAARI is the First and Only Therapy Proven to Prevent AHP Attacks, Reduce Chronic Pain and Improve Quality of…
− GIVLAARI is the First and Only Therapy Proven to Prevent AHP Attacks, Reduce Chronic Pain and Improve Quality of…
DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Packaging Equipment – Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering. Pharmaceutical Packaging…
–TIMEPOINT study expands pioneering results of MTL-CEBPA in liver cancer into additional cancer patient populations– LONDON–(BUSINESS WIRE)–MiNA Therapeutics, the pioneer…
Company bolsters presence in China with appointment of Qing (Steven) Chen as General Manager and the establishment of a WFOE…